Literature DB >> 22167502

Serial evaluation of high-resolution CT findings in patients with pneumonia in novel swine-origin influenza A (H1N1) virus infection.

P Li1, J-F Zhang, X-D Xia, D-J Su, B-L Liu, D-L Zhao, Y Liu, D-H Zhao.   

Abstract

OBJECTIVES: The purpose of our study was to review the changes in the serial high-resolution CT (HRCT) findings from patients with novel swine-origin influenza A (H1N1) virus (S-OIV) infection.
METHODS: HRCT findings of 70 patients with presumed or laboratory-confirmed novel S-OIV infection were reviewed. The pattern (consolidation, ground glass, fibrosis and air trapping), distribution and extent of abnormality of the lesions on the HRCT were evaluated at different time points. To assess changes that occurred over time, the CT scans in 56 patients were examined in sequence.
RESULTS: The most common CT findings in patients with S-OIV infection are ground-glass opacities with or without consolidation at the first week. The abnormalities peaked at the second week and resolved after that time, which resulted in substantial reduced residual disease at 4 weeks or later. The development of fibrosis was noted in the first week and peaked at the third week of illness (34.7%), then decreased slowly after that time. The mean time of air trapping being noted after the onset of symptoms was 55.5 ± 20.6 days. Comparing the findings of initial CT, most results (96.4%) of follow-up chest CT findings showed improvement (p<0.01).
CONCLUSION: The abnormalities of ground-glass opacities and/or consolidation on initial CT scans tended to resolve to fibrosis, which then resolved completely or displayed substantially reduced residual disease. HRCT may show more changes in disease progression and play an important role in the evaluation of severe S-OIV.

Entities:  

Mesh:

Year:  2011        PMID: 22167502      PMCID: PMC3474108          DOI: 10.1259/bjr/85580974

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  30 in total

1.  Mechanical ventilation-induced air-space enlargement during experimental pneumonia in piglets.

Authors:  I Goldstein; M T Bughalo; C H Marquette; G Lenaour; Q Lu; J J Rouby
Journal:  Am J Respir Crit Care Med       Date:  2001-03       Impact factor: 21.405

2.  SARS: imaging of severe acute respiratory syndrome.

Authors:  Savvas Nicolaou; Nizar A Al-Nakshabandi; Nestor L Müller
Journal:  AJR Am J Roentgenol       Date:  2003-05       Impact factor: 3.959

3.  A major outbreak of severe acute respiratory syndrome in Hong Kong.

Authors:  Nelson Lee; David Hui; Alan Wu; Paul Chan; Peter Cameron; Gavin M Joynt; Anil Ahuja; Man Yee Yung; C B Leung; K F To; S F Lui; C C Szeto; Sydney Chung; Joseph J Y Sung
Journal:  N Engl J Med       Date:  2003-04-07       Impact factor: 91.245

4.  Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections.

Authors:  James R Gill; Zong-Mei Sheng; Susan F Ely; Donald G Guinee; Mary B Beasley; James Suh; Charuhas Deshpande; Daniel J Mollura; David M Morens; Mike Bray; William D Travis; Jeffery K Taubenberger
Journal:  Arch Pathol Lab Med       Date:  2010-02       Impact factor: 5.534

5.  Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China.

Authors:  Bin Cao; Xing-Wang Li; Yu Mao; Jian Wang; Hong-Zhou Lu; Yu-Sheng Chen; Zong-An Liang; Lirong Liang; Su-Juan Zhang; Bin Zhang; Li Gu; Lian-He Lu; Da-Yan Wang; Chen Wang
Journal:  N Engl J Med       Date:  2009-12-09       Impact factor: 91.245

6.  Imaging findings in a fatal case of pandemic swine-origin influenza A (H1N1).

Authors:  Daniel J Mollura; Deborah S Asnis; Robert S Crupi; Rick Conetta; David S Feigin; Mike Bray; Jeffery K Taubenberger; David A Bluemke
Journal:  AJR Am J Roentgenol       Date:  2009-12       Impact factor: 3.959

7.  Swine-origin influenza A (H1N1) viral infection: radiographic and CT findings.

Authors:  Amr M Ajlan; Brendan Quiney; Savvas Nicolaou; Nestor L Müller
Journal:  AJR Am J Roentgenol       Date:  2009-12       Impact factor: 3.959

8.  Lung pathology in fatal novel human influenza A (H1N1) infection.

Authors:  Thais Mauad; Ludhmila A Hajjar; Giovanna D Callegari; Luiz F F da Silva; Denise Schout; Filomena R B G Galas; Venancio A F Alves; Denise M A C Malheiros; Jose O C Auler; Aurea F Ferreira; Marcela R L Borsato; Stephania M Bezerra; Paulo S Gutierrez; Elia T E G Caldini; Carlos A Pasqualucci; Marisa Dolhnikoff; Paulo H N Saldiva
Journal:  Am J Respir Crit Care Med       Date:  2009-10-29       Impact factor: 21.405

9.  Thin-section CT in patients with severe acute respiratory syndrome following hospital discharge: preliminary experience.

Authors:  Gregory E Antonio; K T Wong; David S C Hui; Alan Wu; Nelson Lee; Edmund H Y Yuen; C B Leung; T H Rainer; Peter Cameron; Sydney S C Chung; Joseph J Y Sung; Anil T Ahuja
Journal:  Radiology       Date:  2003-06-12       Impact factor: 11.105

10.  Pneumonia in novel swine-origin influenza A (H1N1) virus infection: high-resolution CT findings.

Authors:  Ping Li; Dong-Ju Su; Ji-Feng Zhang; Xu-Dong Xia; Hong Sui; Dong-Hui Zhao
Journal:  Eur J Radiol       Date:  2010-06-20       Impact factor: 3.528

View more
  21 in total

1.  Organising pneumonia as a late abnormality in influenza A (H1N1) virus infection.

Authors:  E Marchiori; B Hochhegger; G Zanetti
Journal:  Br J Radiol       Date:  2012-06       Impact factor: 3.039

2.  Influenza promotes collagen deposition via αvβ6 integrin-mediated transforming growth factor β activation.

Authors:  Lisa Jolly; Anastasios Stavrou; Gilles Vanderstoken; Victoria A Meliopoulos; Anthony Habgood; Amanda L Tatler; Joanne Porte; Alan Knox; Paul Weinreb; Shelia Violette; Tracy Hussell; Martin Kolb; Martin R Stampfli; Stacey Schultz-Cherry; Gisli Jenkins
Journal:  J Biol Chem       Date:  2014-10-22       Impact factor: 5.157

3.  Organizing pneumonia as a pulmonary sequela of swine flu.

Authors:  Gláucia Zanetti; Bruno Hochhegger; Edson Marchiori
Journal:  Lung India       Date:  2013-04

4.  Influenza A (H1N1) pneumonia: HRCT findings.

Authors:  Viviane Brandão Amorim; Rosana Souza Rodrigues; Miriam Menna Barreto; Gláucia Zanetti; Bruno Hochhegger; Edson Marchiori
Journal:  J Bras Pneumol       Date:  2013 May-Jun       Impact factor: 2.624

5.  Thin-section computed tomography detects long-term pulmonary sequelae 3 years after novel influenza A virus-associated pneumonia.

Authors:  Zhi-Heng Xing; Xin Sun; Long Xu; Qi Wu; Li Li; Xian-Jie Wu; Xu-Guang Shao; Xin-Qian Zhao; Jing-Hua Wang; Long-Yan Ma; Kai Wang
Journal:  Chin Med J (Engl)       Date:  2015-04-05       Impact factor: 2.628

6.  Swine flu fibrosis: Regressive or progressive?

Authors:  Nishtha Singh; Sheetu Singh; Bharat Bhushan Sharma; Virendra Singh
Journal:  Lung India       Date:  2016 Mar-Apr

7.  IL-6 ameliorates acute lung injury in influenza virus infection.

Authors:  Mei-Lin Yang; Chung-Teng Wang; Shiu-Ju Yang; Chia-Hsing Leu; Shun-Hua Chen; Chao-Liang Wu; Ai-Li Shiau
Journal:  Sci Rep       Date:  2017-03-06       Impact factor: 4.379

8.  miR-29a is a negative regulator of influenza virus infection through targeting of the frizzled 5 receptor.

Authors:  Xiaoyun Yang; Yurong Liang; Gayan Bamunuarachchi; Yanzhao Xu; Kishore Vaddadi; Samuel Pushparaj; Dao Xu; Zhengyu Zhu; Rachel Blaha; Chaoqun Huang; Lin Liu
Journal:  Arch Virol       Date:  2020-11-18       Impact factor: 2.574

9.  CT findings in viral lower respiratory tract infections caused by parainfluenza virus, influenza virus and respiratory syncytial virus.

Authors:  Min-Chul Kim; Mi Young Kim; Hyun Joo Lee; Sang-Oh Lee; Sang-Ho Choi; Yang Soo Kim; Jun Hee Woo; Sung-Han Kim
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

10.  Macrophage PPAR-γ suppresses long-term lung fibrotic sequelae following acute influenza infection.

Authors:  Su Huang; Nick P Goplen; Bibo Zhu; In Su Cheon; Youngmin Son; Zheng Wang; Chaofan Li; Qigang Dai; Li Jiang; Min Xiang; Eva M Carmona; Robert Vassallo; Andrew H Limper; Jie Sun
Journal:  PLoS One       Date:  2019-10-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.